The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor
Abstract
Neuroendocrine tumors (NETs) are rare, slow-growing neoplasms characterized by their ability to store and secrete different peptides and neuroamines.1 Some of these substances cause specific clinical syndromes,2 whereas other may have elevated plasma or urine levels that are not associated with specific syndromes or symptom complexes Unfortunately, there is no "ideal neuroendocrine tumor marker,"3 but according to the presentation, the sensitivity and specificity of each marker vary, and it is generally possible to choose those of greatest value for each clinical syndrome. The biochemical markers are those hormones or amines secreted by the neuroendocrine cells from which these tumors are derived. Some of these are not specific to any tumor, but are produced and secreted by most NETs, whereas other biochemical markers are more specific to the type of tumor and where their quantification can lead to the suspicion or confirmation of the presence of such a tumor. The annual incidence of NETs has risen to 40 to 50 cases per million, perhaps because of better diagnosis and the availability of highly specific and sensitive ways to measure these tumors' products, improved immunohistochemistry, and enhanced techniques for tumor detection. Thus, the perceived increase in incidence may not be a real change in the incidence of the disease. There are a number of impediments to the diagnosis of these tumors. They are rare, comprising less than 2% of gastrointestinal (GI) malignancies, and are therefore not high on the list of causes of specific symptom complexes. Symptoms themselves are often nonspecific and do not lend themselves readily to identifying the specific underlying tumor. In addition, the manifestations are protean and mimic a variety of disorders. Tumors may be found incidentally on laparoscopy for abdominal pain or during the surgical removal of an appendix or even during a computerized tomographic scan of the abdomen for unexplained symptoms. Lung carcinoids may present with hemoptysis or asthma-like symptoms, and midgut carcinoids may be confused with irritable bowel syndrome (IBS). The natural history of this disease is invariably attended by a long history of vague abdominal symptoms, a series of visits to a primary care practitioner, and referral to a gastroenterologist, often with a misdiagnosis of IBS. These symptoms persist with a median latency to correct diagnosis of 9.2 years by which time the tumor has metastasized, causing symptoms such as flushing and diarrhea and progressing on its slow but relentless course until the patient dies. Clearly, a greater index of suspicion and a carcinoid tumor profile screen are warranted for all patients presenting with "traditional IBS symptoms." Midgut carcinoids are associated with mesenteric fibrosis, which can compress mesenteric vessels and cause bowel ischemia and malabsorption, which may be found in the absence of an abdominal mass. The diagnosis of metastases to the liver is generally more obvious but often still takes place only after a delay of many years. Even then, an incorrect diagnosis is not uncommon. Unless biopsy material is examined for the secretory peptides chromogranin, synaptophysin, or neuron-specific enolase (NSE), tumors may be labeled erroneously as adenocarcinoma, with a negative impact on physician's attitudes regarding management and underestimation of prospects for survival.4 The common symptomatic manifestations of patients with carcinoid tumors are illustrated in Tables 1 and 2.TABLE 1: Clinical Presentations, Syndromes, Tumor Types, Sites, and Hormones4TABLE 2: Clinical Presentation, Syndrome, Tumor Type of Ectopic Pancreatic Tumors, and the Hormones ProducedFlushing It is vitally important to obtain a good history of the nature of the flushing to ascertain whether this can be ascribed to a NET. Is the flushing wet or dry? If dry, it is almost always due to a NET. If it is wet, it may still be due to a NET, but the diaphoresis is due to coexistent anxiety. Intermittent flushing suggests menopause or a NET, for example, systemic mastocytosis or pheochromocytoma. Constant flushing is found with alcoholism, polycythemia, and mitral valve disease, either stenosis or prolapse. If there is a facial rash, it may be rosacea, and if more diffuse, consider mastocytosis with the attendant dermatographia or If there are associated symptoms or such as this suggests a NET, either carcinoid or of the with mastocytosis or and suggests or in NETs is different on the of the tumor. The flushing in carcinoid tumors is dry, long and and has a or in to the common in other It is to and in the and but can the and it can lead to a after Midgut In midgut it is to and the and as as the The is by and and the may and It is only a and may many per many patients may a with a and The diagnosis of flushing the of and and all those causes from a carcinoid tumor, the in the of the it is to is the flushing of and in carcinoid syndrome has ascribed to and the of
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 1×
“In some cases, a serum midnight cortisol or dexamethasone-corticotropin releasing hormone test should be done.(103)”
BackgroundCONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Self-citationLenders, J. W., Eisenhofer, G., Mannelli, M., & Pacak, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,524
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?
Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134
Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., & Virgolini, I. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035667 · Cited by 1,010
The Chromogranin–Secretogranin Family
Taupenot, L., Harper, K. L., & O'Connor, D. T. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021405 · Cited by 819
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Metz, D. C., & Jensen, R. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.047 · Cited by 816
Kebebew, E., Ituarte, P. H. G., Siperstein, A. E., Duh, Q.-Y., & Clark, O. H. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1139::aid-cncr26>3.0.co;2-z · Cited by 684
Genetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Öberg, K., Kvols, L., Caplin, M., Delle Fave, G., de Herder, W., Rindi, G., Ruszniewski, P., Woltering, E. A., & Wiedenmann, B. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh216 · Cited by 577
Self-citationClinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes
Benn, D. E., Gimenez-Roqueplo, A.-P., Reilly, J. R., Bertherat, J., Burgess, J., Byth, K., Croxson, M., Dahia, P. L. M., Elston, M., Gimm, O., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1862 · Cited by 570
Brown, J. E., Cook, R. J., Major, P., Lipton, A., Saad, F., Smith, M., Lee, K.-A., Zheng, M., Hei, Y.-J., & Coleman, R. E. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji002 · Cited by 559
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaître, X. (2003) · PubMed · Cited by 547
Endocrine tumours of the pancreas
Öberg, K., & Eriksson, B. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.06.002 · Cited by 543
Surgery to Cure the Zollinger–Ellison Syndrome
Norton, J. A., Fraker, D. L., Alexander, H. R., Venzon, D. J., Doppman, J. L., Serrano, J., Goebel, S. U., Peghini, P. L., Roy, P. K., Gibril, F., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908263410902 · Cited by 504
Sawka, A. M., Jaeschke, R., Singh, R. J., & Young, W. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021251 · Cited by 503
Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results
Eisenhofer, G., Goldstein, D. S., Walther, M. M., Friberg, P., Lenders, J. W. M., Keiser, H. R., & Pacak, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030005 · Cited by 492
Jensen, R. T., Berna, M. J., Bingham, D. B., & Norton, J. A. (2008) · Cancer · doi:10.1002/cncr.23648 · Cited by 488
Weber, H. C., Venzon, D. J., Lin, J.-T., Fishbein, V. A., Orbuch, M., Strader, D. B., Gibril, F., Metz, D. C., Fraker, D. L., Norton, J. A., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90124-8 · Cited by 467
Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center
Janson, E. T., Holmberg, L., Stridsberg, M., Eriksson, B., Theodorsson, E., Wilander, E., & öberg, K. (1997) · Annals of Oncology · doi:10.1023/a:1008215730767 · Cited by 455
Gibril, F., Reynolds, J. C., Doppman, J. L., Chen, C. C., Venzon, D. J., Termanini, B., Weber, H. C., Stewart, C. A., & Jensen, R. T. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00005 · Cited by 440
Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior
Rindi, G., Bordi, C., Rappel, S., La Rosa, S., Stolte, M., & Solcia, E. (1996) · World Journal of Surgery · doi:10.1007/s002689900026 · Cited by 433
Somatostatinoma Syndrome: Biochemical, Morphologic and Clinical Features
Krejs, G. J., Orci, L., Conlon, J. M., Ravazzola, M., Davis, G. R., Raskin, P., Collins, S. M., McCarthy, D. M., Baetens, D., Rubenstein, A., et al. (1979) · New England Journal of Medicine · doi:10.1056/nejm197908093010601 · Cited by 395
Regulatory Peptides of the Hypothalamus
Vale, W., Rivier, C., & Brown, M. (1977) · Annual Review of Physiology · doi:10.1146/annurev.ph.39.030177.002353 · Cited by 392
Costante, G., Meringolo, D., Durante, C., Bianchi, D., Nocera, M., Tumino, S., Crocetti, U., Attard, M., Maranghi, M., Torlontano, M., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1590 · Cited by 372
Nobels, F. R. E., Kwekkeboom, D. J., Coopmans, W., Schoenmakers, C. H. H., Lindemans, J., De Herder, W. W., Krenning, E. P., Bouillon, R., & Lamberts, S. W. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4145 · Cited by 352
Zollinger-Ellison Syndrome: Clinical Presentation in 261 Patients
Roy, P. K., Venzon, D. J., Shojamanesh, H., Abou-Saif, A., Peghini, P., Doppman, J. L., Gibril, F., & Jensen, R. T. (2000) · Medicine · doi:10.1097/00005792-200011000-00004 · Cited by 351
Eisenhofer, G., Lenders, J. W. M., Linehan, W. M., Walther, M. M., Goldstein, D. S., & Keiser, H. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402404 · Cited by 349
Klöppel, G., Couvelard, A., Perren, A., Komminoth, P., McNicol, A.-M., Nilsson, O., Scarpa, A., Scoazec, J.-Y., Wiedenmann, B., Papotti, M., et al. (2009) · Neuroendocrinology · doi:10.1159/000182196 · Cited by 343
Yu, F., Venzon, D. J., Serrano, J., Goebel, S. U., Doppman, J. L., Gibril, F., & Jensen, R. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.615 · Cited by 341
Timmers, H. J. L. M., Kozupa, A., Chen, C. C., Carrasquillo, J. A., Ling, A., Eisenhofer, G., Adams, K. T., Solis, D., Lenders, J. W. M., & Pacak, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6297 · Cited by 340
Orlefors, H., Sundin, A., Garske, U., Juhlin, C., Oberg, K., Skogseid, B., Langstrom, B., Bergstrom, M., & Eriksson, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1938 · Cited by 329
Pheochromocytomas: Detection with18F DOPA Whole-Body PET—Initial Results
Hoegerle, S., Nitzsche, E., Altehoefer, C., Ghanem, N., Manz, T., Brink, I., Reincke, M., Moser, E., & Neumann, H. P. H. (2002) · Radiology · doi:10.1148/radiol.2222010622 · Cited by 325
Larsson, L.-I., Holst, J. J., Kühl, C., Lundqvist, G., Hirsch, M. A., Ingemansson, S., Lindkaer Jensen, S., Rehfeld, J. F., & Schwartz, T. W. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92113-4 · Cited by 318
Brouwers, F. M., Eisenhofer, G., Tao, J. J., Kant, J. A., Adams, K. T., Linehan, W. M., & Pacak, K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0423 · Cited by 316
Gibril, F., Schumann, M., Pace, A., & Jensen, R. T. (2004) · Medicine · doi:10.1097/01.md.0000112297.72510.32 · Cited by 313
KRENNING, E. P., KOOIJ, P. P. M., BAKKER, W. H., BREEMAN, W. A. P., POSTEMA, P. T. E., KWEKKEBOOM, D. J., OEI, H. Y., de JONG, M., VISSER, T. J., REIJS, A. E. M., et al. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17300.x · Cited by 313
Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy-d-glucose PET
Shulkin, B. L., Thompson, N. W., Shapiro, B., Francis, I. R., & Sisson, J. C. (1999) · Radiology · doi:10.1148/radiology.212.1.r99jl3035 · Cited by 305
Tumor Markers in Neuroendocrine Tumors
Eriksson, B., Öberg, K., & Stridsberg, M. (2000) · Digestion · doi:10.1159/000051853 · Cited by 299
Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma
de Herder, W. W., Niederle, B., Scoazec, J.-Y., Pauwels, S., Klöppel, G., Falconi, M., Kwekkeboom, D. J., Öberg, K., Eriksson, B., Wiedenmann, B., et al. (2006) · Neuroendocrinology · doi:10.1159/000098010 · Cited by 295
HL-A ANTIGENS IN MYASTHENIA GRAVIS
Fritze, D., Herrmann, C., Naeim, F., Smith, G., & Walford, R. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91370-1 · Cited by 294
“Somatostatinoma”: A Somatostatin-Containing Tumor of the Endocrine Pancreas
Ganda, O. P., Weir, G. C., Soeldner, J. S., Legg, M. A., Chick, W. L., Patel, Y. C., Ebeid, A. M., Gabbay, K. H., & Reichlin, S. (1977) · New England Journal of Medicine · doi:10.1056/nejm197704282961703 · Cited by 290
Bajetta, E., Ferrari, L., Martinetti, A., Celio, L., Procopio, G., Artale, S., Zilembo, N., Di Bartolomeo, M., Seregni, E., & Bombardieri, E. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990901)86:5<858::aid-cncr23>3.0.co;2-8 · Cited by 289
Sundin, A., Vullierme, M.-P., Kaltsas, G., & Plöckinger, U. (2009) · Neuroendocrinology · doi:10.1159/000184855 · Cited by 287
Localization of Insulinomas to Regions of the Pancreas by Intra-arterial Stimulation with Calcium
Doppman, J. L., Chang, R., Fraker, D. L., Norton, J. A., Alexander, H. R., Miller, D. L., Collier, E., Skarulis, M. C., & Gorden, P. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-4-199508150-00004 · Cited by 286
Gastrinoma (Duodenal and Pancreatic)
Jensen, R. T., Niederle, B., Mitry, E., Ramage, J. K., Steinmüller, T., Lewington, V., Scarpa, A., Sundin, A., Perren, A., Gross, D., et al. (2006) · Neuroendocrinology · doi:10.1159/000098009 · Cited by 284
Grant, C. S. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.05.008 · Cited by 281
Timmers, H. J. L. M., Kozupa, A., Eisenhofer, G., Raygada, M., Adams, K. T., Solis, D., Lenders, J. W. M., & Pacak, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2315 · Cited by 276
Cohen, R. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.919 · Cited by 274
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
Falconi, M., Plöckinger, U., Kwekkeboom, D. J., Manfredi, R., Körner, M., Kvols, L., Pape, U. F., Ricke, J., Goretzki, P. E., Wildi, S., et al. (2006) · Neuroendocrinology · doi:10.1159/000098012 · Cited by 257
Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma
Hirshberg, B., Livi, A., Bartlett, D. L., Libutti, S. K., Alexander, H. R., Doppman, J. L., Skarulis, M. C., & Gorden, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6807 · Cited by 256
[123I]Metaiodobenzylguanidine and[111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas1
van der Harst, E., de Herder, W. W., Bruining, H. A., Bonjer, H. J., de Krijger, R. R., Lamberts, S. W. J., van de Meiracker, A. H., Boomsma, F., Stijnen, T., Krenning, E. P., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7238 · Cited by 253
Pheochromocytoma: The expanding genetic differential diagnosis.
Bryant, J., Farmer, J., Kessler, L. J., Townsend, R. R., & Nathanson, K. L. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg024 · Cited by 250
Ilias, I., Yu, J., Carrasquillo, J. A., Chen, C. C., Eisenhofer, G., Whatley, M., McElroy, B., & Pacak, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030235 · Cited by 241
Norton, J. A., & Jensen, R. T. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000143252.02142.3e · Cited by 237
Zollinger-Ellison Syndrome: Current Concepts and Management
JENSEN, R. T., GARDNER, J. D., RAUFMAN, J.-P., PANDOL, S. J., DOPPMAN, J. L., & COLLEN, M. J. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-1-59 · Cited by 221
Berna, M. J., Hoffmann, K. M., Serrano, J., Gibril, F., & Jensen, R. T. (2006) · Medicine · doi:10.1097/01.md.0000236956.74128.76 · Cited by 221
Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid
Feldman, J., & Lee, E. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/42.4.639 · Cited by 219
Curative Resection in Zollinger-Ellison Syndrome Results of a 10-Year Prospective Study
NORTON, J. A., DOPPMAN, J. L., & JENSEN, R. T. (1992) · Annals of Surgery · doi:10.1097/00000658-199201000-00012 · Cited by 218
Imaging and localization of islet-cell tumours of the pancreas on CT and MRI.
Noone, T. C., Hosey, J., Firat, Z., & Semelka, R. C. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.013 · Cited by 217
Imaging of neuroendocrine tumours (CT/MR/US)
Rockall, A. G., & Reznek, R. H. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.01.003 · Cited by 216
Libutti, S. K., Choyke, P. L., Bartlett, D. L., Vargas, H., Walther, M., Lubensky, I., Glenn, G., Linehan, W. M., & Alexander, H. R. (1998) · Surgery · doi:10.1067/msy.1998.91823 · Cited by 213
Paragangliomas: Clinical Overview
YOUNG, W. F. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.002 · Cited by 210
Termanini, B., Gibril, F., Reynolds, J., Doppman, J., Chen, C., Stewart, C., Sutliff, V., & Jensen, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024287 · Cited by 206
The glucagonoma syndrome and necrolytic migratory erythema: a clinical review
van Beek, A., de Haas, E., van Vloten, W., Lips, C., Roijers, J., & Canninga-van Dijk, M. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510531 · Cited by 202
Management of the Zollinger–Ellison syndrome in patients with multiple endocrine neoplasia type 1
Jensen (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00281.x · Cited by 200
Hoffmann, K. M., Furukawa, M., & Jensen, R. T. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.05.009 · Cited by 199
Neuroendocrine tumors of the pancreas: Spectrum of appearances on MRI
Semelka, R. C., Custodio, C. M., Balci, N. C., & Woosley, J. T. (2000) · Journal of Magnetic Resonance Imaging · Cited by 197
Glucagon-like Peptide 1–Receptor Scans to Localize Occult Insulinomas
Wild, D., Mäcke, H., Christ, E., Gloor, B., & Reubi, J. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0802045 · Cited by 192
Berna, M. J., Hoffmann, K. M., Long, S. H., Serrano, J., Gibril, F., & Jensen, R. T. (2006) · Medicine · doi:10.1097/md.0b013e31802b518c · Cited by 188
Lee, C., Lu, S., Changchien, C., Yeh, C., Tt, H., Tang, J., Wang, J.-H., Lin, D., Chen, C., & Chen, W. J. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991001)86:7<1377::aid-cncr38>3.0.co;2-7 · Cited by 187
Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors
Feldman, J. M., & O'dorisio, T. M. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90583-8 · Cited by 184
Self-citationNorton, J. A., Alexander, H. R., Fraker, D. L., Venzon, D. J., Gibril, F., & Jensen, R. T. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000124290.05524.5e · Cited by 178
Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours
Nehar, D., Lombard‐Bohas, C., Olivieri, S., Claustrat, B., Chayvialle, J., Penes, M., Sassolas, G., & Borson‐Chazot, F. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02030.x · Cited by 177
Neuroendocrine tumors of the gastro-entero-pancreatic system.
Massironi, S., Sciola, V., Peracchi, M., Ciafardini, C., Spampatti, M. P., & Conte, D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5377 · Cited by 177
Sj, M., Agarwal, S. K., Kester, M. B., Heppner, C., Ys, K., Skarulis, M. C., La, J., Goldsmith, P. K., Saggar, S. K., Sy, P., et al. (1999) · PubMed · Cited by 173
Cushing's Syndrome in Patients with the Zollinger–Ellison Syndrome
Maton, P. N., Gardner, J. D., & Jensen, R. T. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607033150101 · Cited by 168
Norton, J. A., Cornelius, M. J., Doppman, J. L., Maton, P. N., Gardner, J. D., & Jensen, R. T. (1987) · PubMed · Cited by 164
Endoscopic ultrasound in the localisation of pancreatic islet cell tumours.
McLean, A. M., & Fairclough, P. D. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.012 · Cited by 163
Choi, I.-S., Estecio, M. R. H., Nagano, Y., Kim, D. H., White, J. A., Yao, J. C., Issa, J.-P. J., & Rashid, A. (2007) · Modern Pathology · doi:10.1038/modpathol.3800825 · Cited by 161
Nuclear imaging of neuroendocrine tumours
Sundin, A., Garske, U., & Örlefors, H. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.12.003 · Cited by 160
Somatostatin‐receptor Scintigraphy in Gastroenteropancreatic Tumors: An Overview of European Results
KRENNING, E. P., KWEKKEBOOM, D. J., OEI, H. Y., de JONG, R. J. B., DOP, F. J., REUBI, J. C., & LAMBERTS, S. W. J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17291.x · Cited by 159
Gibril, F., Reynolds, J. C., Chen, C. C., Yu, F., Goebel, S. U., Serrano, J., Doppman, J. L., & Jensen, R. T. (1999) · PubMed · Cited by 159
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study
Zatelli, M. C., Torta, M., Leon, A., Ambrosio, M. R., Gion, M., Tomassetti, P., De Braud, F., Delle Fave, G., Dogliotti, L., Uberti, E. C. D., et al. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-07-0001 · Cited by 159
A Prospective Study of Intraoperative Methods to Diagnose and Resect Duodenal Gastrinomas
Sugg, S. L., Norton, J. A., Fraker, D. L., Metz, D. C., Pisegna, J. R., Fishbeyn, V. A., Benya, R. V., Shawker, T. H., Doppman, J. L., & Jensen, R. T. (1993) · Annals of Surgery · doi:10.1097/00000658-199308000-00004 · Cited by 155
Kytölä, S. I., Höög, A., Nord, B., Cedermark, B., Frisk, T., Larsson, C., & Kjellman, M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64136-3 · Cited by 154
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
Pacák, K., Eisenhofer, G., & Goldstein, D. S. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0032 · Cited by 154
Well-Differentiated Gastric Tumors/Carcinomas
Ruszniewski, P. B., Fave, G. D., Cadiot, G., Komminoth, P., Chung, D. C., Kos‐Kudła, B., Kianmanesh, R., Hochhauser, D., Arnold, R., Ahlman, H., et al. (2006) · Neuroendocrinology · doi:10.1159/000098007 · Cited by 153
Norton, J. A., Venzon, D. J., Berna, M. J., Alexander, H. R., Fraker, D. L., Libutti, S. K., Marx, S. J., Gibril, F., & Jensen, R. T. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815efda5 · Cited by 153
Biochemistry of neuroendocrine tumours
de Herder, W. W. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.12.002 · Cited by 153
Chromogranin A: its clinical value as marker of neuroendocrine tumours.
Nobels, Kwekkeboom, Bouillon, & Lamberts (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00305.x · Cited by 151
Characteristics of Pheochromocytoma in a 4‐ to 20‐Year‐Old Population
Barontini, M., Levin, G. M., & Sansó, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.003 · Cited by 143
Manger, W. M., & Gifford, R. W. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.01452.x · Cited by 143
Gibril, F., Doppman, J. L., Reynolds, J. C., Chen, C. C., Sutliff, V. E., Yu, F., Serrano, J., Venzon, D. J., & Jensen, R. T. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1040 · Cited by 142
Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study
Gullo, L., Migliori, M., Falconi, M., Pederzoli, P., Bettini, R., Casadei, R., Fave, G. D., Corleto, V. D., Ceccarelli, C., Santini, D., et al. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07704.x · Cited by 141
Biochemical Testing for Neuroendocrine Tumors
Vinik, A. I., Silva, M. P., Woltering, G., Go, V. L. W., Warner, R., & Caplin, M. E. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181bc0e77 · Cited by 138
Self-citationRare Functioning Pancreatic Endocrine Tumors
O’Toole, D., Salazar, R., Falconi, M., Kaltsas, G., Couvelard, A., de Herder, W. W., Hyrdel, R., Nikou, G. C., Krenning, E. P., Vullierme, M., et al. (2006) · Neuroendocrinology · doi:10.1159/000098011 · Cited by 136
Self-citationLocation, incidence, and malignant potential of duodenal gastrinomas.
Thom, A. K., Norton, J. A., Axiotis, C. A., & Jensen, R. T. (1991) · PubMed · Cited by 134
Gastric Secretion in Zollinger-Ellison Syndrome
Roy, P. K., Venzon, D. J., Feigenbaum, K. M., Koviack, P. D., Bashir, S., Ojeaburu, J. V., Gibril, F., & Jensen, R. T. (2001) · Medicine · doi:10.1097/00005792-200105000-00005 · Cited by 133
Bhattacharyya, S., Toumpanakis, C., Caplin, M. E., & Davar, J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.047 · Cited by 130
Self-citationKlöppel, G., & Anlauf, M. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.02.010 · Cited by 129
Consequences of Long‐Term Proton Pump Blockade: Insights from Studies of Patients with Gastrinomas
Jensen, R. T. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_378.x · Cited by 129
Bhatia, K. S. S., Ismail, M., Sahdev, A., Rockall, A., Hogarth, K. M., Canizales, A., Avril, N. E., Monson, J. P., Grossman, A. B., & Reznek, R. H. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03256.x · Cited by 127
Biochemical Diagnosis and Localization of Pheochromocytoma
Grossman, A. B., Pacák, K., Sawka, A. M., Lenders, J. W. M., HARLANDER, D., Peaston, R., Reznek, R. H., Sisson, J. C., & Eisenhofer, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.038 · Cited by 127
Detection of duodenal gastrinomas by operative endoscopic transillumination
Frucht, H., Norton, J. A., London, J. F., Vinayek, R., Doppman, J. L., Gardner, J. D., Jensen, R. T., & Maton, P. N. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90466-e · Cited by 125
Norton, J. A., Melcher, M. L., Gibril, F., & Jensen, R. T. (2004) · Surgery · doi:10.1016/j.surg.2004.06.057 · Cited by 123
Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours
Turner, G. B., Johnston, B. T., McCance, D. R., et al. (2006) · Gut · doi:10.1136/gut.2006.092320 · Cited by 123
Is Supine Rest Necessary before Blood Sampling for Plasma Metanephrines?
Lenders, J. W. M., Willemsen, J. J., Eisenhofer, G., Ross, H. A., Pacák, K., Timmers, H. J. L. M., & Sweep, F. C. G. J. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.076489 · Cited by 120
Panzuto, F., Severi, C., Cannizzaro, R., Falconi, M., Angeletti, S., Pasquali, A., Corleto, V. D., Annibale, B., Buonadonna, A., Pederzoli, P., et al. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03350903 · Cited by 118
Kindmark, H., Sundin, A., Granberg, D. O., Dunder, K., Skogseid, B. M., Janson, E. T., Welin, S., Öberg, K., & Eriksson, B. (2007) · Medical Oncology · doi:10.1007/s12032-007-0011-2 · Cited by 117
Lamberts, S. W. J., Hofland, L. J., & Nobels, F. R. E. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0218 · Cited by 115
Timmers, H. J. L. M., Hadi, M., Carrasquillo, J. A., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042721 · Cited by 114
Lumachi, F., Tregnaghi, A., Zucchetta, P., Marzola, M. C., Cecchin, D., Grassetto, G., & Bui, F. (2006) · Nuclear Medicine Communications · doi:10.1097/00006231-200607000-00006 · Cited by 113
Gibril, F., & Jensen, R. T. (2003) · Digestive and Liver Disease · doi:10.1016/j.dld.2003.11.024 · Cited by 108
Won, J. G. S., Tseng, H., Yang, A., Tang, K., Jap, T., Lee, C. H., Lin, H., Burcus, N. I., Pittenger, G. L., & Vinik, A. I. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02629.x · Cited by 108
Self-citationAlgeciras‐Schimnich, A., Preissner, C. M., Young, W. F., Singh, R. J., & Grebe, S. K. G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1354 · Cited by 106
Güller, U., Turek, J., Eubanks, S., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000193833.51108.24 · Cited by 106
Kann, P. H., Balakina, E., Ivan, D., Bartsch, D. K., Meyer, S., Klose, K., Behr, T., & Langer, P. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01220 · Cited by 106
Tanaka, S., Yamasaki, S., Matsushita, H., Ozawa, Y., Kurosaki, A., Takeuchi, K., Hoshihara, Y., Doi, T., WATANABE, G., & Kawaminami, K. (2000) · Pathology International · doi:10.1046/j.1440-1827.2000.01016.x · Cited by 103
Langer, P., Kann, P. H., Fendrich, V., Richter, G., Diehl, S., Rothmund, Μ., & Bartsch, D. K. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7642-7 · Cited by 102
Imaging appearances of metastases from neuroendocrine tumours of the pancreas
Debray, M., Geoffroy, O., Laissy, J., Lebtahi, R., Silbermann-Hoffman, O., Henry–Feugeas, M.-C., Cadiot, G., Mignon, M., & Schouman‐Claeys, E. (2001) · British Journal of Radiology · doi:10.1259/bjr.74.887.741065 · Cited by 100
Transhepatic portal vein catheterization for localization of insulinomas: a ten-year experience.
Vinik, A. I., Delbridge, L., Moattari, R., Cho, K., & Thompson, N. W. (1991) · PubMed · Cited by 99
Self-citationRoutine serum calcitonin measurement in the evaluation of thyroid nodules
Elisei, R. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.008 · Cited by 98
Shulkin, B. L., Koeppe, R. A., Francis, I. R., Deeb, G. M., Lloyd, R. V., & Thompson, N. W. (1993) · Radiology · doi:10.1148/radiology.186.3.8430179 · Cited by 93
Developments in PET for the detection of endocrine tumours
Eriksson, B., Örlefors, H., Öberg, K., Sundín, A., Bergström, M., & Långström, B. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.001 · Cited by 93
Nuclear medicine in the detection and management of pancreatic islet-cell tumours.
Virgolini, I., Traub-Weidinger, T., & Decristoforo, C. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.09.001 · Cited by 93
Chromogranin A. Storage and release in hypertension.
TAKIYYUDDIN, M. A., Cervenka, J. H., Hsiao, R., Barbosa, J. A., Parmer, R. J., & O’Connor, D. T. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.237 · Cited by 91
Gibril, F., & Jensen, R. T. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0067-5 · Cited by 91
Corleto, V. D., Annibale, B., Gibril, F., Angeletti, S., Serrano, J., Venzon, D. J., Fave, G. D., & Jensen, R. T. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01085.x · Cited by 91
Jackson, J. E. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.10.002 · Cited by 89
Effects of Somatostatin on Gallbladder Emptying
Fisher, R. S., Rock, E., Levin, G. B., & Malmud, L. S. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90961-9 · Cited by 87
Somatostatin and the stomach: Exocrine and endocrine aspects
Creutzfeldt, W., & Arnold, R. (1978) · Metabolism · doi:10.1016/0026-0495(78)90064-1 · Cited by 84
Vinik, A., Levitt, N. S., Pimstone, B. L., & Wagner, L. M. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-2-330 · Cited by 84
Self-citationWang, G. G., Yao, J. C., Worah, S., White, J. A., Luna, R., Wu, T., Hamilton, S. R., & Rashid, A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800389 · Cited by 80
Recent advances in the diagnosis and treatment of pheochromocytoma in children
Ludwig, A. D., Feig, D. I., Brandt, M. L., Hicks, J. M., Fitch, M. E., & Cass, D. L. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.08.028 · Cited by 74
Gibril, F., Reynolds, J. C., Lubensky, I. A., Roy, P. K., Peghini, P. L., Doppman, J. L., & Jensen, R. T. (2000) · PubMed · Cited by 72
Jensen, E. H., Kvols, L. K., McLoughlin, J. M., Lewis, J. M., Alvarado, M. D., Yeatman, T. J., Malafa, M. P., & Shibata, D. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9148-z · Cited by 72
Etıt, D., Faquin, W. C., Gaz, R. D., Randolph, G. W., DeLellis, R. A., & Pilch, B. Z. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/132.11.1767 · Cited by 68
Measurements of chromogranin B can serve as a complement to chromogranin A
Stridsberg, M., Eriksson, B. K., Fellström, B., Kristiansson, G., & Janson, E. T. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.10.008 · Cited by 68
The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid
Tormey, W. P., & Fitzgerald, R. J. (1995) · Postgraduate Medical Journal · doi:10.1136/pgmj.71.839.542 · Cited by 67
Imaging of neuroendocrine tumours
Wieshmann, N. H., Cuthbertson, D. J., & Hughes, S. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.07.030 · Cited by 66
Samols, E., Weir, G. C., Ramseur, R., Day, J. A., & Patel, Y. (1978) · Metabolism · doi:10.1016/0026-0495(78)90046-x · Cited by 64
Sporadic hypercalcitoninemia: clinical and therapeutic consequences
Scheuba, C., Kaserer, K., Moritz, A., Drosten, R., Vierhapper, H., Bieglmayer, C., Haas, O. A., & Niederle, B. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0059 · Cited by 64
Gola, M., Doga, M., Bonadonna, S., Mazziotti, G., Vescovi, P. P., & Giustina, A. (2006) · Pituitary · doi:10.1007/s11102-006-0267-0 · Cited by 62
A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours
BERNINI, G. P., Moretti, A., Ferdeghini, M., Ricci, S., Letizia, C., D'Erasmo, E., Argenio, G. F., & Salvetti, A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1659 · Cited by 56
Thakker, R. V. (2001) · Hormone Research in Paediatrics · doi:10.1159/000048138 · Cited by 56
Circulating markers for endocrine tumours of the gastroenteropancreatic tract
Ardill, J. E. S. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2008.008039 · Cited by 54
The glucagon-like polypeptides ? order out of chaos?
Conlon, J. M. (1980) · Diabetologia · doi:10.1007/bf00290482 · Cited by 51
Metastatic gastrinomas: localization with selective arterial injection of secretin.
Gibril, F., Doppman, J. L., Chang, R., Weber, H. C., Termanini, B., & Jensen, R. T. (1996) · Radiology · doi:10.1148/radiology.198.1.8539410 · Cited by 48
Bílek, R., Šafařík, L., Ciprová, V., Vlček, P., & Lisá, L. (2008) · Physiological Research · doi:10.33549/physiolres.931502 · Cited by 47
Tachykinins in endocrine tumors and the carcinoid syndrome
Cunningham, J. L., Janson, E. T., Agarwal, S., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0196 · Cited by 47
Diagnosis and differential diagnosis of hypergastrinemia
Arnold, R. (2007) · Wiener klinische Wochenschrift · doi:10.1007/s00508-007-0878-0 · Cited by 47
Frequent Genetic Changes in Childhood Pheochromocytomas
de Krijger, R. R., van Nederveen, F. H., Korpershoek, E., de Herder, W. W., Keizer-Schrama, S. M. P. F. D. M., & Dinjens, W. N. M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.017 · Cited by 45
Mackenzie, I. S., Gurnell, M., Balan, K., Simpson, H., Chatterjee, K., & Brown, M. J. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0369 · Cited by 45
Manfrédi, S., Pagenault, M., de Lajarte‐Thirouard, A., & Bretagne, J. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328220eae0 · Cited by 43
Malignant Somatostatinoma: Clinical Features and Metabolic Studies*
Axelrod, L., Bush, M. A., Hirsch, H. J., & Loo, S. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-5-886 · Cited by 41
Stronge, R. L., Turner, G. B., Johnston, B. T., et al. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2008.008033 · Cited by 41
Intraoperative Ultrasound of the Pancreas
Shin, L. K., Brant-Zawadzki, G. M., Kamaya, A., & Jeffrey, R. B. (2009) · Ultrasound Quarterly · doi:10.1097/ruq.0b013e3181901ce4 · Cited by 40
Giovanella, L., Squin, N., Ghelfo, A., & Ceriani, L. (2006) · PubMed · Cited by 40
ATROPINE SUPPRESSION TEST FOR PANCREATIC POLYPEPTIDE
Schwartz, T. W. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91349-1 · Cited by 39
Vinik, A. I., Gonin, J. M., England, B. G., et al. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1702 · Cited by 38
Self-citationBiochemical diagnosis of neuroendocrine GEP tumor.
Öberg, K. (1999) · PubMed · Cited by 33
Quinkler, M. O., Strelow, F., Pirlich, M., Rohde, W., Biering, H., Lochs, H. H., Gerl, H., Strasburger, C. J., & Ventz, M. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-982516 · Cited by 33
Demonstration of Somatostatin Production in Medullary Carcinoma of the Thyroid
Sano, T., Kagawa, N., Hizawa, K., et al. (1980) · Japanese Journal of Clinical Oncology · doi:10.1093/oxfordjournals.jjco.a038677 · Cited by 23
Ishii, E., Kimura, N., Kato, K., Sako, M., Nagano, M., Nakagawa, A., Okamura, T., Yamaguchi, H., Kawa, K., & Hara, T. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990401)85:7<1470::aid-cncr7>3.0.co;2-s · Cited by 17
Cited by
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
Self-citationJensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
Francis, J. M., Kiezun, A., Ramos, A. H., Serra, S., Pedamallu, C. S., Qian, Z. R., Banck, M. S., Kanwar, R., Kulkarni, A. A., Karpathakis, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2821 · Cited by 369
Self-citationDeppen, S. A., Blume, J., Bobbey, A. J., Shah, C., Graham, M. M., Lee, P., Delbeke, D., & Walker, R. C. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.165803 · Cited by 264
Innovative imaging of insulinoma: the end of sampling? A review
Christ, E., Antwi, K., Fani, M., & Wild, D. (2020) · Endocrine-Related Cancer · doi:10.1530/erc-19-0476 · Cited by 78
Metadata
- Authors
- Vinik, A. I., Woltering, E. A., Warner, R. R. P., Caplin, M., O'Dorisio, T. M., Wiseman, G. A., Coppola, D., & Go, V. L. W.
- Venue
- Pancreas
- Published
- 2010-08
- Volume
- 39
- Issue
- 6
- Pages
- 713-734
- ISSN
- 0885-3177 (ISSN-L)
- OpenAlex
- W1969709966
- Cited by
- 287
- References
- 168
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.